🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of Muscle Training Device on Non-Severe OSA

RecruitingNAAges 18 Years - anyAllThammasat University Hospital
NCT06910930 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The goal of this clinical trial is to test for the efficacy of the newly invented device #DidgeriTU with non-severe obstructive sleep apnea. The main question it aims to answer is: • Can DidgeriTU reduce apnea events in patients with non-severe obstructive sleep apnea? Researchers will compare DidgeriTU with a sham device to see how the apnea event has changed. Participants will: * Use DidgeriTU or sham device for 3 month * Do an online questionnaire once a month during the study * Home sleep test, lung function test, and tongue strength test at the start and end of the study

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients diagnosed with mild to moderate obstructive sleep apnea. * Age 18 years or older. * Patients voluntarily consent to provide information for research purposes. Exclusion Criteria: * Patients with an average apnea-hypopnea index (AHI) of \<4 or \>29 events per hour after repeated diagnosis using a home sleep apnea test. * Patients who refused to cease using CPAP during the study process * Patients with a history of chronic lung disease. * Elderly patients with neurological conditions that impair cognitive function, such as dementia, stroke, or psychiatric disorders. * Patients taking medications that may affect muscle function within 3 months before the start of the study. * Patients with hypothyroidism or other conditions that may affect muscle function. * Patients who consume alcohol at a moderate level or higher
💊

What it tests

  • DidgeriTU
  • Sham device
📍

Where

1 site
Thammasat University Hospital
Pathum Thani, Thailand
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy